J N Sheagren. Show Affiliations »
Abstract
Entities: Species
Mesh: See more » Anti-Bacterial Agents/administration & dosageAnti-Bacterial Agents/therapeutic useAntibodies, Bacterial/analysisAntigens, Bacterial/analysisBacterial Toxins/biosynthesisBlood/microbiologyCarrier State/drug therapyDrug Resistance, MicrobialHumansNose/microbiologyRifampin/therapeutic useSepsis/diagnosisShock, Septic/etiologyStaphylococcal Infections/diagnosisStaphylococcal Infections/drug therapyStaphylococcal Infections/prevention & controlStaphylococcus aureus/isolation & purificationStaphylococcus aureus/metabolismStaphylococcus aureus/pathogenicityStevens-Johnson Syndrome/etiologyTeichoic Acids/immunology
Substances: See more » Anti-Bacterial AgentsAntibodies, BacterialAntigens, BacterialBacterial ToxinsTeichoic AcidsRifampin
Year: 1984 PMID: 6371536 DOI: 10.1056/NEJM198405313102206
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245